THE COMPLEMENT-SYSTEM IN TRAUMA-RELATED AND ISCHEMIC TISSUE-DAMAGE - A BRIEF REVIEW

被引:51
作者
MOLLNES, TE
FOSSE, E
机构
[1] UNIV TROMSO, TROMSO, NORWAY
[2] ULLEVAL UNIV HOSP, DEPT CARDIOVASC & THORAC SURG, OSLO, NORWAY
来源
SHOCK | 1994年 / 2卷 / 04期
关键词
D O I
10.1097/00024382-199410000-00012
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
There is increasing evidence that the complement system plays an important role in tissue damage associated with trauma and ischemia. In the present review we focus on some principles of importance for a basic understanding of the complement system, particularly aimed at those not working in this field. Complement is activated by its ability to discriminate between self and non-self, primarily as a defense against microorganisms. The activation induces an inflammatory reaction which may lead to harmful effects on the host, either as local tissue damage or, in case of an extensive systemic activation, as breakdown of homeostatic mechanisms. Complement-mediated inflammation is important not only in specific immunological defense reactions, but also in the induction of tissue injury by ischemia, hypothermia or other general tissue-damaging factors. Major trauma leads to systemic complement activation and complications to trauma may enhance the activation and increase the risk of development of the whole body inflammatory reaction and even of a fatal outcome. To protect the host against self-damage, complement activation is controlled by a series of regulatory proteins inhibiting at the various levels of the cascade. Intervening with complement activation using regulatory proteins like soluble complement receptor 1 has provided direct evidence for the importance of complement in tissue damage in various experimental models. Therapeutic complement intervention using a similar approach may be a useful tool in selected patients to attenuate the degree of complement activation and thereby reduce the total inflammatory load.
引用
收藏
页码:301 / 310
页数:10
相关论文
共 142 条
[31]   HEPARIN-COATED CIRCUITS REDUCE THE INFLAMMATORY RESPONSE TO CARDIOPULMONARY BYPASS [J].
GU, YJ ;
VANOEVEREN, W ;
AKKERMAN, C ;
BOONSTRA, PW ;
HUYZEN, RJ ;
WILDEVUUR, CRH .
ANNALS OF THORACIC SURGERY, 1993, 55 (04) :917-922
[32]   ENDOTOXIN-INDUCED PULMONARY DYSFUNCTION IS PREVENTED BY C1-ESTERASE INHIBITOR [J].
GUERRERO, R ;
VELASCO, F ;
RODRIGUEZ, M ;
LOPEZ, A ;
ROJAS, R ;
ALVAREZ, MA ;
VILLALBA, R ;
RUBIO, V ;
TORRES, A ;
DELCASTILLO, D .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2754-2760
[33]   COMPLEMENT 5A INDUCES INVIVO SYNTHESIS OF CYSTEINYL LEUKOTRIENES IN RATS [J].
GULBINS, E ;
SIOW, Y ;
VITALE, GC .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1993, 48 (04) :331-334
[34]   ELEVATED PLASMA-LEVELS OF THE ANAPHYLATOXINS C3A AND C4A ARE ASSOCIATED WITH A FATAL OUTCOME IN SEPSIS [J].
HACK, CE ;
NUIJENS, JH ;
FELTBERSMA, RJF ;
SCHREUDER, WO ;
EERENBERGBELMER, AJM ;
PAARDEKOOPER, J ;
BRONSVELD, W ;
THIJS, LG .
AMERICAN JOURNAL OF MEDICINE, 1989, 86 (01) :20-26
[35]  
HACK CE, 1992, LANCET, V339, P378
[36]   COMPLEMENT ACTIVATION AND HYPERSENSITIVITY REACTIONS TO DIALYSIS MEMBRANES [J].
HAKIM, RM ;
BREILLATT, J ;
LAZARUS, JM ;
PORT, FK .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (14) :878-882
[37]  
HAMMERSCHMIDT DE, 1981, AM J PATHOL, V102, P146
[38]  
HAMMERSCHMIDT DE, 1980, LANCET, V1, P947
[39]   COMPLEMENT LEVELS IN SEPTIC PRIMATES TREATED WITH ANTI-C5A ANTIBODIES [J].
HANGEN, DH ;
STEVENS, JH ;
SATOH, PS ;
HALL, EW ;
OHANLEY, PT ;
RAFFIN, TA .
JOURNAL OF SURGICAL RESEARCH, 1989, 46 (03) :195-199
[40]  
HANSCH GM, 1989, CURR TOP MICROBIOL, V140, P109